Test Price
3,000 AED✅ Home Collection Available
Pancreatitis Panel Genetic Test (NGS) in the UAE – Diagnostic Risk Assessment
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO 15189 accredited NGS processing.
- Premium Logistics: VIP mobile phlebotomy and temperature-controlled cold-chain home collection available daily 8 AM – 11 PM.
- Clinical Guidance: Post-test telephonic interpretation by a Consultant Medical Genetics specialist.
- Insurance Support: Direct billing verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The Pancreatitis Panel Genetic Test analyzes 28 genes associated with hereditary pancreatitis and pancreatic cancer susceptibility using next-generation sequencing (NGS). This advanced molecular assay identifies pathogenic variants in PRSS1, SPINK1, CFTR, CTRC, and 24 additional genes implicated in recurrent acute pancreatitis, chronic pancreatitis, and familial pancreatic cancer syndromes. Results are correlated with clinical history and imaging by a Consultant Medical Geneticist.
| Feature | Our Test – NGS Panel (28 Genes) | Alternative – Single-Gene Testing |
|---|---|---|
| Scope | Simultaneous sequencing of 28 genes in one workflow | One gene per test; sequential reflex testing required |
| Methodology | Next-Generation Sequencing (NGS) with >99.9% sensitivity | Sanger sequencing or MLPA; lower throughput |
| Turnaround Time | 21–28 days (3–4 weeks) | 2–3 weeks per gene cumulatively slower for multi-gene assessment |
| Clinical Utility | Comprehensive risk stratification for hereditary pancreatitis and pancreatic cancer predisposition | Limited mutation detection; may miss secondary findings |
Physician Insight & Safety Protocols
“I emphasize that this genetic panel is a risk assessment tool, not a diagnostic substitute for acute pancreatitis. Results must be interpreted in conjunction with clinical history, pancreatic imaging, and biochemical markers by a qualified genetic specialist. Patients should continue all prescribed medications and never discontinue them without consulting their physician.” – Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory & Safety Considerations
Safety Exclusion Criteria & Emergency Red Flags
- Exclusion: This test is not intended for diagnosing acute pancreatitis. It is designed for individuals with chronic or recurrent pancreatitis, a family history of pancreatic cancer, or suspected hereditary syndromes.
- Red Flag: If you develop sudden severe upper abdominal pain radiating to the back, jaundice, persistent vomiting, or high fever, seek emergency medical care immediately.
- Medication Advisory: Do not discontinue any prescribed medications without consulting your physician.
Exclusion Criteria
Who Should Not Take This Test
- Individuals presenting with acute abdominal pain of unknown origin without prior specialist evaluation.
- Patients currently undergoing active chemotherapy for pancreatic malignancy without genetic counseling.
- Minors under 18 years without parental/guardian consent and prior genetics consultation.
- Individuals with a prior bone marrow transplant (risk of chimeric results in whole blood samples).
Patient FAQ & Clinical Guidance
1. Can this test definitively rule out all pancreatic diseases?
This genetic panel identifies inherited mutations linked to pancreatitis risk but does not rule out non-genetic causes, acute episodes, gallstone-induced disease, or other pancreatic disorders. A comprehensive clinical evaluation remains essential for diagnosis.
2. How long do results take and what do they mean for my family?
Results are ready in 3 to 4 weeks. The report provides inherited mutation status that may guide family cascade screening and preventive strategies. Genetic counseling is recommended for first-degree relatives if a pathogenic variant is identified.
3. Will my insurance cover the cost of this genetic panel?
Many UAE insurers reimburse this advanced panel when deemed medically necessary. Our direct billing verification via WhatsApp enables real-time eligibility checks and pre-authorization support.
4. Is home sample collection available for this test?
Yes. A trained phlebotomist collects a peripheral whole blood sample at your home or office (daily 8 AM – 11 PM). The sample is transported under temperature-controlled cold chain to our ISO-accredited laboratory.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance & Data Protection
- All genetic data is processed and stored in compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL).
- Health information handling adheres to Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
- Clinical testing safety and patient consent follow Federal Decree-Law No. 4 of 2016 on Medical Liability.
- DNA Labs UAE is DHA-licensed (Facility License 1143) and operates under ISO 15189 quality standards.
Clinical & Logistical Metadata
| Test Name | Pancreatitis Panel Genetic Test (NGS) – 28-Gene Profile |
| Price (AED) | 3,000 AED |
| Turnaround Time | 21–28 Days (3–4 Weeks) |
| Sample Type / Matrix | Peripheral Whole Blood – 2 mL in EDTA Tube |
| Methodology Used | Next-Generation Sequencing (NGS) – Targeted Gene Panel |
| ICD-10-CM Code | K86.1, Z15.09 |
| LOINC Code | 94227-4 |
| DHA Facility License & Laboratory Address | DNA Labs UAE | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DHA License No. 1143 |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians